Skip to main content

Table 2 Quality evaluation of the included studies with ROB 2.0

From: Efficacy and safety of stem cell therapy for Crohn’s disease: a meta-analysis of randomized controlled trials

Study

Randomization process

Deviations from intended interventions

Missing outcome data

Measurement of the outcome

Selection of the reported result

Overall bias

Garcia-Olmo 2009

Low risk

Low risk

Low risk

Low risk

Low risk

Low risk

Molendijk 2015

Low risk

Low risk

Low risk

Low risk

Low risk

Low risk

Melmed 2015

Some concerns

Low risk

Low risk

Low risk

Low risk

Some concerns

Hawkey 2015

Low risk

Low risk

Low risk

High risk

Low risk

High risk

Panés 2016

Low risk

Low risk

Low risk

Low risk

Low risk

Low risk

Zhang 2018

Some concerns

Low risk

Low risk

High risk

Low risk

High risk

Zhou 2020

Low risk

Low risk

Low risk

High risk

Low risk

High risk

Ascanelli 2021

Low risk

Low risk

Low risk

Low risk

Low risk

Low risk

Lightner 2022

Some concerns

Low risk

Low risk

High risk

Low risk

High risk

Lightner 2023a

Low risk

Low risk

Low risk

High risk

Low risk

High risk

Lightner 2023b

Low risk

Low risk

Low risk

High risk

Low risk

High risk

Lightner 2023c

Low risk

Low risk

Low risk

High risk

Low risk

High risk